Dipartimento di Scienze Statistiche, Sapienza University of Rome, Roma, Italy.
Int J Biostat. 2022 Apr 27;19(1):177-189. doi: 10.1515/ijb-2021-0120. eCollection 2023 May 1.
Non-inferiority vaccine trials compare new candidates to active controls that provide clinically significant protection against a disease. Bayesian statistics allows to exploit pre-experimental information available from previous studies to increase precision and reduce costs. Here, historical knowledge is incorporated into the analysis through a power prior that dynamically regulates the degree of information-borrowing. We examine non-inferiority tests based on credible intervals for the unknown effects-difference between two vaccines on the log odds ratio scale, with an application to new Covid-19 vaccines. We explore the frequentist properties of the method and we address the sample size determination problem.
非劣效性疫苗试验将新候选疫苗与能对疾病提供临床显著保护的活性对照进行比较。贝叶斯统计学允许利用来自先前研究的实验前信息来提高精度和降低成本。在这里,历史知识通过一个动力先验被纳入分析,该先验动态调节信息借用的程度。我们检验了基于两个疫苗在对数几率比尺度上的未知效应差异的可信区间的非劣效性检验,应用于新的 COVID-19 疫苗。我们探讨了该方法的频率性质,并解决了样本量确定问题。